ELISpot and FluoroSpot Assay Market Research Report – Global Forecast till 2027

ELISpot and FluoroSpot Assay Market Research Report, by Product (Assay Kit, Ancillary Products), Application (Transplant, Vaccines), End-User (Hospitals and Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Research Centers) – Forecast Till 2027

ID: MRFR/LS/5483-HCR | February, 2021 | Region : Global

ELISpot and FluoroSpot Assay Market Scenario:


The ELISpot and FluoroSpot Assay Market were estimated USD 135 million in 2017 and expected to reach USD 287 million by 2023 at a CAGR of 16.2 % during the forecast period.


ELISpot and FluoroSpot Assay are a sensitive technique used for the recognition of immune cells which specific proteins such as cytokines or antibodies. These asses are used in hospitals and research institutes for early diagnosis for diseases such as TB and other viral infection. The FluoroSpot assay is a modification of ELISpot in which combinations of monoclonal antibodies with different reagents are used to detect the infection. The key factor responsible for driving the market growth are increasing incidence of chronic diseases, rising vaccine development to solve the challenge of antimicrobial resistance, technological advancements in analyzers and ELISpot and FluoroSpot assay kits. However, the factors such as lack of skilled technicians, and alternative detection technologies may limit the ELISpot and FluoroSpot Assay Market growth during the forecast period. 


Segmentation:


The ELISpot and FluoroSpot Assay Market is segmented on the basis of product, application, and end-user. The market, by product is categorised into various assay kit, analyzer, ancillary products. The assay kit is sub-segmented into T Cell assay and B Cell assay. On the basis of application, the market is segmented into transplant, vaccines development, clinical trials, cancer treatment. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic centres, research centers, and others.


On the basis of region, the ELISpot and FluoroSpot Assay Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players:


Some of the key players in the ELISpot and FluoroSpot Assay Market are Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), and Abcam (UK)Bio-Techne (US), Autoimmun Diagnostika (Germany), Biotech Investissement (France), Lophius Biosciences (Germany), and U-CyTech (Netherlands), and Others.


Regional Market Summary:


Global ELISpot and FluoroSpot Assay Market Share (%), by Region, 2017


Sources: National Cancer Institute, Cancer research UK, the American Cancer Society, Inc, US Department of Health and Human Services National Institutes of HealthIt is estimated that North America dominated the ELISpot and FluoroSpot Assay Market owing to the increasing cardiac diseases, innovations in clinical practice, increasing research and development in pharmaceutical industries boost the market growth. According to the Centers for Disease Control and Prevention 2017 publication 83.4% of children aged 19-35 months were vaccinated with Diphtheria, Tetanus, Pertussis in the US. The increasing demand for vaccines will boost the market growth.


Europe stood second largest in the ELISpot and FluoroSpot Assay market owing to the increasing number of pharmaceutical companies, rising in the development of innovative vaccines for the treatment of various viral diseases. The growing funding from government and private agencies for drug development also support the market in this region.  Asia-Pacific was estimated to be the fastest growing region for the Market in 2017. The market is expected to witness growth owing to the rising prevalence of viral infection, increasing geriatric population in this region and growing demand for ELISpot and FluoroSpot Assay in research field.


The Middle East and Africa holds the least share in the ELISpot and FluoroSpot Assay Market due to the presence of low health expenditure, lack of skilled technicians and less pharmaceutical company in this region. However, the market is expected to witness growth due to increasing research & development in the Middle East.


Market Segmentation and Key Market Players:


Market of ELISpot and FluoroSpot Assay, by Product:



  • Assay Kit


    •  T Cell assay

    • B Cell assay


  • Analyzer

  • Ancillary Products 


Market of ELISpot and FluoroSpot Assay, by Application:



  • Transplant,

  • Vaccines

  • Clinical Trials

  • Cancer Treatment


ELISpot and FluoroSpot Assay Market, by End-Users:



  • Hospitals and clinics

  • Ambulatory surgical centers

  • Diagnostic centers

  • Research centers

  • Others


ELISpot and FluoroSpot Assay Market, by Region:



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa 


Intended Audience:



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global ELISpot and FluoroSpot Assay Market, by Product

6.1 Introduction

6.2 Assay Kit

6.2.1 T Cell assay

6.2.2 B Cell assay

6.3 Ancillary Products

6.4 Analyzer

Chapter 7. Global ELISpot and FluoroSpot Assay Market, by Application

7.1 Introduction

7.2 Transplant

7.3 Vaccines

7.4 Clinical Trials

7.5 Cancer

Chapter 8. Global ELISpot and FluoroSpot Assay Market, by End-Users

8.1 Introduction

8.2 Hospitals and clinics

8.3 Ambulatory Surgical Centers

8.4 Diagnostic Centers

8.5 Research centers

8.6 Others

Chapter 9. Global ELISpot and FluoroSpot Assay Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Oxford Immunotec

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials

11.2.4 Key Developments

11.1.5 SWOT Analysis

11.2 Cellular Technologies

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Mabtech

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Abcam

11.4.1 Company Overview

11.4.2 Type/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Becton, Dickinson and Company

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Bio-Techne

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Autoimmun Diagnostika

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 BIOTECH INVESTISSEMENT

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Lophius Biosciences

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 U-CYTECH

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Others

Chapter 12 Appendix

LIST OF TABLES

Table 1 Global ELISpot and FluoroSpot Assay Market Industry Synopsis, 2020-2027

Table 2 Global ELISpot and FluoroSpot Assay Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global ELISpot and FluoroSpot Assay Market, by Region, 2020-2027, (USD Million)

Table 4 Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 5 Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 6 Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 7 North America: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 8 North America: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 9 North America: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 10 US: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 11 US: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 12 US: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 13 Canada: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 14 Canada: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 15 Canada: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 16 South America: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 17 South America: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 18 South America: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 19 Europe: Global ELISpot and FluoroSpot Assay Market, Product, 2020-2027, (USD Million)

Table 20 Europe: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 21 Europe: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 22 Western Europe: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 23 Western Europe: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 24 Western Europe: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 25 Eastern Europe: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 26 Eastern Europe: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 27 Eastern Europe: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 28 Asia-Pacific: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 29 Asia-Pacific: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 30 Asia-Pacific: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

Table 31 Middle East & Africa: Global ELISpot and FluoroSpot Assay Market, by Product, 2020-2027, (USD Million)

Table 32 Middle East & Africa: Global ELISpot and FluoroSpot Assay Market, by Application, 2020-2027, (USD Million)

Table 33 Middle East & Africa: Global ELISpot and FluoroSpot Assay Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for the Global ELISpot and FluoroSpot Assay Market

Figure 3 Market Dynamics for the Global ELISpot and FluoroSpot Assay Market

Figure 4 Global ELISpot and FluoroSpot Assay Market Share, by Product 2020

Figure 5 Global ELISpot and FluoroSpot Assay Market Share, by Application, 2020

Figure 6 Global ELISpot and FluoroSpot Assay Market Share, by End-User, 2020

Figure 7 Global ELISpot and FluoroSpot Assay Market Share, by Region, 2020

Figure 8 North America ELISpot and FluoroSpot Assay Market Share, by Country, 2020

Figure 9 Europe Prescribed Health Apps Share, by Country, 2020

Figure 10 Asia-Pacific ELISpot and FluoroSpot Assay Market Share, by Country, 2020

Figure 11 Middle East & Africa ELISpot and FluoroSpot Assay Market Share, by Country, 2020

Figure 12 Global ELISpot and FluoroSpot Assay Market: Company Share Analysis, 2020 (%)

Figure 13 Oxford Immunotec : Key Financials

Figure 14 Oxford Immunotec : Segmental Revenue

Figure 15 Oxford Immunotec : Geographical Revenue

Figure 16 Cellular Technologies : Key Financials

Figure 17 Cellular Technologies : Segmental Revenue

Figure 18 Cellular Technologies : Geographical Revenue

Figure 19 Mabtech : Key Financials

Figure 20 Mabtech : Segmental Revenue

Figure 21 Mabtech : Geographical Revenue

Figure 22 Abcam: Key Financials

Figure 23 Abcam: Segmental Revenue

Figure 24 Abcam: Geographical Revenue

Figure 25 Becton, Dickinson and Company: Key Financials

Figure 26 Becton, Dickinson and Company: Segmental Revenue

Figure 27 Becton, Dickinson and Company: Geographical Revenue

Figure 28 Bio-Techne : Key Financials

Figure 29 Bio-Techne : Segmental Revenue

Figure 30 Bio-Techne : Geographical Revenue

Figure 31 Autoimmun Diagnostika: Key Financials

Figure 32 Autoimmun Diagnostika: Segmental Revenue

Figure 33 Autoimmun Diagnostika: Geographical Revenue

Figure 34 BIOTECH INVESTISSEMENT : Key Financials

Figure 35 BIOTECH INVESTISSEMENT : Segmental Revenue

Figure 36 BIOTECH INVESTISSEMENT : Geographical Revenue

Figure 37 Lophius Biosciences : Key Financials

Figure 38 Lophius Biosciences : Segmental Revenue

Figure 39 Lophius Biosciences : Geographical Revenue

Figure 40 U-CYTECH: Key Financials

Figure 41 U-CYTECH: Segmental Revenue

Figure 42 U-CYTECH: Geographical Revenue